SEC v. Dhia Jafar et al: First Amended Complaint

First Amended Complaint alleging insider trading involving the securities of Life Technologies Corp. and Onyx Pharmaceuticals Inc. in the U. S. Securities and Exchange Commission in Dhia Jafar, a.k.a. Dhia Yahya Dhia Al-Din Jaffar, described as an Iraq-born citizen of Belize residing in Dubai, and Omar Nabulsi, of Jordan, at the U. S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 43

Date: December 23, 2013

Defendants/Respondents: Dhia Jafar, Omar Nabulsi

Plaintiffs/Applicants: U. S. Securities and Exchange Commission

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities, Regulatory

Allegation: Fraud

Topics

Listed Securities Regulatory United Arab Emirates

[ 3 more... ] [ top 5 ]

Keywords

Amgen Dhia Yahya Dhia Al-Din Jaffar Life Technologies Corp. Omar Nabulsi Onyx Pharmaceuticals

Thermo Fisher Scientific

[ 1 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.